Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Participation
$0.00
During this 36-minute video, Dr. Thanh Nguyen takes us through the origin of COVID-19 and its impact on stroke care - both for patients and clinicians. Note: Dr. Nguyen obtained permission to use the images used in this presentation and offered disclosures at the start of the presentation.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
$0.00
In this 19-minute video, Dr. Jee Bang provides an overview of the current state of research and therapy for Huntington Disease.
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Participation
$0.00
In this 12-minute video, Dr. Basil Darras, Professor of Neurology at Boston Children’s Hospital and Harvard Medical School, introduces the learner to spinal muscular atrophy (SMA), the number one genetic cause of death in infants. SMA is a genetic disorder characterized by degeneration and loss of motor neurons in the anterior horns of the spinal cord and brain stem of children and adults, with limited involvement of peripheral organs in severely affected patients. What are the extra-neuronal phenotypes of SMA in humans and animal models? Part 1 of 2.
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Participation
$0.00
In part 2 of this series, Dr. Crystal Yeo, Assistant Professor at LKC School of Medicine, Associated Staff at Boston Children’s Hospital, joint Medical Director at EDDC and Group Leader at IMCB, continues on to review the changing therapeutic landscape for spinal muscular atrophy (SMA), the extra-neuronal expression of survival motor neuron (SMN) protein, and motor neuron cell-non-autonomous rescue in animal models. What are the clinical implications for patients treated with SMN protein augmenting interventions?
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Hosted by Drs. Jason Hinman & Bhooma Aravamuthan, and featuring panelists Drs. David Holtzman, Rachel Salas, and Kathrin LaFaver, this 60 minute event focused on the spectrum of professional networking featuring an introduction to how to network at conferences in person and how to network on Twitter and Facebook, followed by suggestions from everyone via a panel Q and A on how one might network at virtual meetings, including the virtual ANA meeting in 2020.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
During this 60-minute session, Dr. John Ciotti hosted Drs. Elena Grebenciucova, Scott Newsome, and Brandon Moss discussing implications of disease-modifying therapies for MS on COVID-19 susceptibility/severity, starting/switching therapies, vaccine responses, and other clinical considerations.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation
$0.00
During this 90-minute session, Dr. Rebecca Gottesman moderated a panel discussion to explore questions related to successful mentorship of clinician-scientists. Dr. Stephen Korn from the NINDS reviewed NINDS-specific K criteria, and panelists discussed questions such as: role of a mentor in K application preparation; dedication of time and resources to mentees and mentorship; approaches to effective communication between mentors and mentees; and responsibility of a mentor in transitions to independence.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
During this 60-minute session, Drs. Ken Tyler and Igor Koralnik review updates on neurological manifestations of COVID-19 and answer questions related to the article on this topic in the July issue of the Annals of Neurology.
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Participation
$0.00
Functional Movement Disorders (FMD) are as prevalent as Multiple Sclerosis (MS) yet remain understudied. Like MS, FMD predominantly affect women, has historically been referred to as “hysteria” or “conversion disorder” and remains a highly stigmatized condition. In this 43 minute video, Dr. LaFaver walks us through history, etiology, diagnostic considerations, and treatment options for FMD.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
$0.00
Cerebral palsy (CP) does not end in childhood. NEW neurologic concerns can emerge in adults with CP which require ongoing neurologic surveillance and treatment. The Annals of Neurology article "Adults with Cerebral Palsy Require Ongoing Neurologic Care: A Systematic Review" highlights these concerns and also highlights areas for further research into the manifestations of CP in adulthood. Meet the authors during this one-hour webinar.